ELI LILLY & Co — Investor Relations & Filings
Filings indexed
3,870
across all filing types
Latest filing
2024-01-10
Director's Dealing
Country
US
United States of America
Listing
US
LLY
Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2024 | 2024-01-10 | English | |
| Director's Dealing 2024 | 2024-01-05 | English | |
| Regulatory Filings 2024 | 2024-01-04 | English | |
| SC TO-T/A Filing | 2023-12-26 | English | |
| FORM 4 | 2023-12-19 | English | |
| FORM 4 | 2023-12-19 | English |
Browse filings by year
27 years- 2026 62 filings
- 2025 215 filings
- 2024 206 filings
- 2023 240 filings
- 2022 209 filings
- 2021 166 filings
- 2020 138 filings
- 2019 264 filings
- 2018 243 filings
- 2017 173 filings
- 2016 157 filings
- 2015 131 filings
- 2014 151 filings
- 2013 115 filings
- 2012 97 filings
- 2011 110 filings
- 2010 92 filings
- 2009 100 filings
- 2008 157 filings
- 2007 146 filings
- 2006 225 filings
- 2005 170 filings
- 2004 165 filings
- 2003 100 filings
- 2002 14 filings
- 2001 13 filings
- 2000 11 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
3 filings
| |||||
| 9101323 | Director's Dealing 2024 | 2024-01-10 | English | ||
| 9101322 | Director's Dealing 2024 | 2024-01-05 | English | ||
| 9101326 | Regulatory Filings 2024 | 2024-01-04 | English | ||
|
2023
12 filings
| |||||
| 15958110 | SC TO-T/A Filing | 2023-12-26 | English | ||
| 9101325 | FORM 4 | 2023-12-19 | English | ||
| 9101324 | FORM 4 | 2023-12-19 | English | ||
| 9101328 | FORM 4 | 2023-12-19 | English | ||
| 9101327 | FORM 4 | 2023-12-19 | English | ||
| 9101329 | FORM 4 | 2023-12-19 | English | ||
| 9101330 | FORM 4 | 2023-12-19 | English | ||
| 15958052 | SC TO-T/A Filing | 2023-12-18 | English | ||
| 9101331 | FORM 4 | 2023-12-04 | English | ||
| 15957900 | SC TO-T/A Filing | 2023-12-04 | English | ||
| 9101333 | FORM 4 | 2023-11-21 | English | ||
| 9101332 | FORM 4 | 2023-11-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ELI LILLY & Co via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29745/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29745 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29745 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29745 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29745}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ELI LILLY & Co (id: 29745)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.